Diagnosing asymptomatic tuberculosis: current approaches, emerging tools, and persistent challenges
5 affiliations
- 1Department of Lab Medicine, Shandong Public Health Clinical Center, Shandong University, Jinan, China
- 2Department Pediatrics, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China
- 3Department Pediatrics, The People’s Hospital of Chongzuo, Chongzuo, Guangxi, China
- 4Department of Tuberculosis, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China
- 5Department of Respiratory Medicine, Shandong Public Health Clinical Center, Shandong University, Jinan, China
Abstract
Asymptomatic tuberculosis is a major but incompletely defined manifestation of the tuberculosis disease spectrum and an important challenge for active case finding. It is best understood as a symptom-defined and method-dependent phenotype rather than a uniform biological stage. Individuals classified as asymptomatic may have minimal or extensive radiographic abnormalities, low or intermittent bacillary shedding, or clinically inapparent disease that remains stable, regresses, fluctuates, or progresses. Differences in terminology, symptom ascertainment, population risk and diagnostic intensity have therefore led to substantial variation in how asymptomatic or subclinical tuberculosis is recognized and interpreted across studies and programmes. This Review examines current and emerging approaches for diagnosing asymptomatic tuberculosis, with emphasis on the interaction between epidemiological risk, radiological detectability, microbiological confirmation and longitudinal follow-up. Symptom-based screening and passive case finding miss a substantial proportion of bacteriologically or radiographically evident tuberculosis. Conventional sputum-based testing is constrained by difficulty obtaining specimens, paucibacillary disease, intermittent shedding and imperfect sensitivity. Chest radiography and computer-aided detection can expand screening capacity and standardize triage, but they cannot independently establish disease activity or exclude tuberculosis. Computed tomography and positron emission tomography/computed tomography provide more sensitive characterization in selected settings, although their cost, accessibility and limited specificity preclude routine use. Non-sputum pathogen assays and host biomarkers are promising because they may reduce dependence on spontaneous sputum, but most remain insufficiently validated, and their incremental clinical or programmatic value over imaging-based triage and conventional confirmation remains uncertain. The diagnostic challenge of asymptomatic tuberculosis lies not simply in the absence of symptoms, but in the unstable boundary between infection, early disease, radiological abnormality, microbiological detectability and future risk. Clinical and public health practice should therefore move beyond single-test strategies toward staged, risk-stratified diagnostic pathways that integrate symptom ascertainment, exposure risk, imaging, confirmatory microbiology, enhanced specimen collection and longitudinal reassessment. Such pathways should be viewed as flexible clinical-programmatic frameworks for organizing diagnostic uncertainty, guiding multidisciplinary decisions and generating testable hypotheses, rather than as validated treatment algorithms.
Related
- Asymptomatic Tuberculosis in the Namibia National Tuberculosis Prevalence Survey: Occurrence Under Various Case Definitions
- Performance of ultra-sensitive electrochemiluminescence LAM assay for diagnosing tuberculosis in HIV-negative individuals: a multicentre, prospective diagnostic study
- Tuberculosis incidence among household contacts of individuals with symptomatic and asymptomatic tuberculosis: A historical cohort study in the Western Cape province of South Africa
- Persistent Hypertension After Asymptomatic Elevated In-Hospital Blood Pressure: The INDEBP Study
- The prevalence and proportion of asymptomatic tuberculosis among adolescents and young adults: a systematic review and meta-analysis.
BibTeX
@article{wang2026diagnosing,
title = {{Diagnosing asymptomatic tuberculosis: current approaches, emerging tools, and persistent challenges}},
author = {Mao-Shui Wang and Dong-Yan Wei and Dong-Yan Wei and Xu-Hui Liu and Zhong-Fa Zhang},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
month = oct,
doi = {10.3389/fcimb.2026.1935260},
url = {https://doi.org/10.3389/fcimb.2026.1935260},
note = {CC BY},
}
RIS
TY - JOUR
TI - Diagnosing asymptomatic tuberculosis: current approaches, emerging tools, and persistent challenges
AU - Mao-Shui Wang
AU - Dong-Yan Wei
AU - Dong-Yan Wei
AU - Xu-Hui Liu
AU - Zhong-Fa Zhang
PY - 2026
DA - 2026/10/27
JO - Frontiers in Cellular and Infection Microbiology
DO - 10.3389/fcimb.2026.1935260
UR - https://doi.org/10.3389/fcimb.2026.1935260
AB - Asymptomatic tuberculosis is a major but incompletely defined manifestation of the tuberculosis disease spectrum and an important challenge for active case finding. It is best understood as a symptom-defined and method-dependent phenotype rather than a uniform biological stage. Individuals classified as asymptomatic may have minimal or extensive radiographic abnormalities, low or intermittent bacillary shedding, or clinically inapparent disease that remains stable, regresses, fluctuates, or progresses. Differences in terminology, symptom ascertainment, population risk and diagnostic intensity have therefore led to substantial variation in how asymptomatic or subclinical tuberculosis is recognized and interpreted across studies and programmes. This Review examines current and emerging approaches for diagnosing asymptomatic tuberculosis, with emphasis on the interaction between epidemiological risk, radiological detectability, microbiological confirmation and longitudinal follow-up. Symptom-based screening and passive case finding miss a substantial proportion of bacteriologically or radiographically evident tuberculosis. Conventional sputum-based testing is constrained by difficulty obtaining specimens, paucibacillary disease, intermittent shedding and imperfect sensitivity. Chest radiography and computer-aided detection can expand screening capacity and standardize triage, but they cannot independently establish disease activity or exclude tuberculosis. Computed tomography and positron emission tomography/computed tomography provide more sensitive characterization in selected settings, although their cost, accessibility and limited specificity preclude routine use. Non-sputum pathogen assays and host biomarkers are promising because they may reduce dependence on spontaneous sputum, but most remain insufficiently validated, and their incremental clinical or programmatic value over imaging-based triage and conventional confirmation remains uncertain. The diagnostic challenge of asymptomatic tuberculosis lies not simply in the absence of symptoms, but in the unstable boundary between infection, early disease, radiological abnormality, microbiological detectability and future risk. Clinical and public health practice should therefore move beyond single-test strategies toward staged, risk-stratified diagnostic pathways that integrate symptom ascertainment, exposure risk, imaging, confirmatory microbiology, enhanced specimen collection and longitudinal reassessment. Such pathways should be viewed as flexible clinical-programmatic frameworks for organizing diagnostic uncertainty, guiding multidisciplinary decisions and generating testable hypotheses, rather than as validated treatment algorithms.
SN - 2235-2988
ER -